Proprietary IPNrgene's proprietary algorithms and genomic tools provide durable differentiation and technical barriers. This IP supports licensing, bespoke services and deeper integration with partner pipelines, enabling recurring fees and higher switching costs that sustain competitive advantage over months.

Diversified Revenue ModelThe mix of per-project service contracts, software licensing and strategic partnerships spreads revenue risk across streams. This multi-channel model supports recurring and milestone-based cash inflows, reduces single-client dependence and enhances resilience over a multi-month horizon.

Balance Sheet ImprovementThe shift away from prior negative equity to a more balanced 2024 structure reduces immediate insolvency risk. Improved leverage gives management more flexibility to fund operations or partnerships and extend runway while addressing operational weaknesses over the medium term.

Bears Say

Steep Revenue DeclineA multi-year drop from $7.6M to $1.29M materially reduces scale and operating leverage. Lower top-line volumes weaken pricing power and margins, constrain R&D and sales investment, and make it difficult to rebuild commercial momentum without new products or sizable new contracts.

Persistent Negative Cash FlowOngoing negative operating and free cash flow signals the company cannot self-fund growth or cover recurring costs. Persistent cash burn increases dependence on external financing, elevates dilution or debt risk, and limits capacity to invest in product development required to reverse declines.

Negative Profitability & Margin ErosionNegative EBIT and shrinking gross margins indicate structural profitability issues. Without margin recovery or sustained revenue growth, losses will likely persist, eroding retained capital and forcing strategic trade-offs between investment, pricing and cost-cutting that impair long-term competitiveness.

NRGN FAQ

What was NRGENE TECHNOLOGIES LTD’s price range in the past 12 months?

NRGENE TECHNOLOGIES LTD lowest stock price was 0.00 and its highest was 390.00 in the past 12 months.

What is NRGENE TECHNOLOGIES LTD’s market cap?

NRGENE TECHNOLOGIES LTD’s market cap is ₪29.76M.

When is NRGENE TECHNOLOGIES LTD’s upcoming earnings report date?

NRGENE TECHNOLOGIES LTD’s upcoming earnings report date is Mar 31, 2026 which is in 42 days.

How were NRGENE TECHNOLOGIES LTD’s earnings last quarter?

NRGENE TECHNOLOGIES LTD released its earnings results on Sep 02, 2025. The company reported -52.5 earnings per share for the quarter, missing the consensus estimate of N/A by -52.5.

Is NRGENE TECHNOLOGIES LTD overvalued?

According to Wall Street analysts NRGENE TECHNOLOGIES LTD’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does NRGENE TECHNOLOGIES LTD pay dividends?

NRGENE TECHNOLOGIES LTD does not currently pay dividends.

What is NRGENE TECHNOLOGIES LTD’s EPS estimate?

NRGENE TECHNOLOGIES LTD’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does NRGENE TECHNOLOGIES LTD have?

NRGENE TECHNOLOGIES LTD has 13,273,517 shares outstanding.

What happened to NRGENE TECHNOLOGIES LTD’s price movement after its last earnings report?

NRGENE TECHNOLOGIES LTD reported an EPS of -52.5 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.383%.

Which hedge fund is a major shareholder of NRGENE TECHNOLOGIES LTD?

Currently, no hedge funds are holding shares in IL:NRGN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

NRGENE TECHNOLOGIES LTD

NRGene Technologies Ltd, an AI genomics company, provides computational tools and develops advanced algorithms in North America, Europe, Middle East, Africa, Asia Pacific, and internationally. It offers software tools; and turnkey solutions to breeding agricultural and food technology companies, academia, research institutes, and agribiotech companies. The company also develops custom panels for various plants including wheat, canola, corn, soybean, maize, etc., as well as cannabis. NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.